Comment on: Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients

J Antimicrob Chemother. 2024 May 9:dkae124. doi: 10.1093/jac/dkae124. Online ahead of print.
No abstract available

Publication types

  • Editorial
  • Comment